Sri Lanka News Search:
Stay Connected
Sponsored Links
Sri Lanka Explorer
Subscribe our Newsletter and receive great deals.


Anti-Suicide Drugs Market – Global Industry Insights, Trends And Opportunity Analysis, 2014-2024

Suicidal thoughts have many causative factors such as depression, no hope in life, substance abuse, post-traumatic stress disorder, bipolar disorder, or financial crisis. Moreover, suicides may be the result of side effects from drugs such as anti-depressants, an overdose of opioids. Treatment for suicidal thoughts includes psychotherapy, medications, addiction treatment, and family support. Medications include antidepressants, anti-anxiety medications, antipsychotic medications, and other medications for mental illness. These medications will only help to reduce the symptoms of suicidal thoughts. Addiction treatment which includes detoxification, self-help group meetings and addiction treatment programs may also help in alleviating the thoughts of suicide.

Increasing Incidences of Suicides Globally

Globally, the World Health Organization (WHO) estimates that over 800,000 people die to suicide every year. When it comes to regional analysis the scenario doesn’t differ much based on the economic status of the country. Suicidal attempts are the highest in emerging nations in Asia, Africa and Eastern Europe followed by the Latina America, the U.S., Australia and some European countries. According to the Centers for Disease Control and Prevention (CDC) estimate, more than 9 million people in the United States reported having suicidal thoughts in 2013. The suicide rates in the country have been increasing according to the American Foundation for Suicide Prevention, reaching a suicide rate of 12.93 per 1,000 populations in 2014.

Get more information @

New Treatment Options under Research

Lack of an effective and focused therapy for suicidal attempts is compelling the use of alternative, less effective and unapproved therapies. Researchers are in an endeavor to find an effective therapeutic solution to this perilous condition. A recent study published in the American Journal of Psychiatry, demonstrated the benefits of administering buprenorphine in curbing the suicidal thoughts after one week of the trial. Anti-depressants and some anti-psychotic medications take longer time to be effective in curing suicidal thoughts. The drug could become the first fast-acting anti-suicide drug in future studies also result with similar findings as in this preliminary study. Although use of opioids also carries a risk of suicidal thoughts and attempts, buprenorphine has the lowest risk amongst the drugs in this class.

Another study from NeuroRx, an Israeli based life science startup found the molecule D-cycloserine and effective treatment option for depression and suicide. D-cycloserine is a N-methyl-D-aspartate (NMDA) antagonist. The drug has shown to reduce the symptoms within two hours of treatment in it Phase 2 trails. Moreover, the positive outcomes were observed to lasts for over eight weeks. The company also found that use of combination therapy which includes ketamine, D-cycloserine and one of three FDA-approved mood stabilizer is much more effective than ketamine alone which is also used by many doctors to treat acute depression. The company expects a fast track approval process for this drug from the U.S. FDA once the clinical trials are completed by the end of 2017.

Ask for Table of Content @

There is a Dire Need for an Effective and Targeted Drug

Suicide is viewed as an end stage of depression, whereas it is a distinct medical condition that needs special attention. The current market for the treatment of suicide is a subset of the drugs used to treat anxiety and depression. A fast track approval of the drug D-cycloserine will help address this unmet medical condition. A recent study carried out by the Nordic Cochrane Centre, with 70 trials involving 18,000 people found that antidepressants doubled the risk of suicide and aggressive behavior in people under the age of 18 years. Therefore, there is dire need for targeted and effective drug to treat suicides.

ABOUT Coherent


Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. Our global team of over 100 research analysts and freelance consultants provide market intelligence from the very molecular country level and also provide a global perspective of the market. Our team is of the most vital cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive defusion training module.This allows for an objective and unbiased assessment of the market. We pride ourselves in my constantly striving to update our extremely in-depth understanding of the market by closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth path in the future.


Coherent Market Insights

303, Astral Court, Above Reliance

Fresh, Near Gaikwad Petrol Pump,

Aundh, Pune – 411045, India.


This email address is being protected from spambots. You need JavaScript enabled to view it.

Aerial Imaging Market: Increase in Applications across Diversified Segments to Bolster Growth Through 2023

Aerial imaging is the process of taking images of the ground from an elevated position, generally from a camera not supported by a ground-based structure. Some of the commonly used platforms for aerial imaging include helicopters, fixed-wing aircraft, multi-rotor unmanned aircraft systems (UAS), dirigibles and blimps, balloons, rockets, parachutes, kites, vehicle-mounted poles, and stand-alone telescoping. Aerial imagery or photography provides effective solutions that combine cost-effectiveness and high precision for planning purposes, volume calculations, route design, or merely to renew existing mapping. The global Aerial Imaging market was valued at US$ 1,077.7 Mn in 2014 and is forecast to grow at a CAGR of 13.5% from 2015 to 2023 reaching a value of US$ 3,341.7 Mn in 2023.

Get Free Sample Report at -

The growing footprint of aerial imaging solutions across various applications such as cartography, defense and security, construction and development, and intelligence surveillance, among others is one of the important factors bolstering the growth of the aerial imaging market. Furthermore, the growing popularity of location-based services and various technological developments in the field of advanced aerial camera systems and platforms is expected to propel market demand throughout the forecast period. Various operational limitations and privacy and national security concerns are the most prominent factors that are currently inhibiting market growth worldwide. The key market players profiled in this report include Major aerial imaging providers profiled in the report include NRC Group ASA (Previously BLOM ASA), Cicade s.a, Digital Aerial Solutions, LLC, Cooper Aerial Surveys Co., Fugro N.V., Landiscor Aerial Information, EagleView Technologies, Inc., and nearmap ltd.

The global aerial imaging market has been segmented on the basis of end-use industry, applications, and geography. On the basis of end-use industry, the market is segmented into government, commercial enterprises, civil engineering industry, military, forestry and agriculture, energy sectors and insurance, among others. Commercial enterprises, government, forestry and agriculture, and civil engineering industry, among others are predicted to be the foremost adopters of aerial imaging solutions in the future.

Based on various aerial imaging applications, the market is classified into energy, geospatial technology, natural resources management, construction and development, disaster response management, defense and intelligence, conservation and research, and media and entertainment. The defense & security sector has always been a prime consumer of aerial imagery and geospatial data. The use of aerial imagery in this sector is now growing due to increased awareness and availability of high-resolution aerial imagery from numerous suppliers. Construction & development, geospatial technology, and natural resource management are emerging as promising applications for the aerial imaging industry.


North America led the Aerial Imaging market in 2014, holding approximately 42% of the global market revenue share and is expected to remain dominant throughout the forecast period from 2015 to 2023. The primary driver for the aerial imaging market in North America is the increasing use of aerial imaging solutions in the agriculture and forestry area. Europe and Asia Pacific is anticipated to hold a promising growth for aerial imaging market in the coming future. This is attributed to the growing use of aerial imaging solutions for archaeological purposes in Europe and growing number of earthquake incidents in Asia Pacific. 

AddThis Social Bookmark Button

Event Calendar

January 2020
29 30 31 1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31 1
Select Category
No events
No events
No events